Clinical trials recruiting for Lung Adenocarcinoma Metastatic
Fewer than 3 recruiting trials found.
2
Recruiting trials
7
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 2 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Aumolertinib combined with phased chemotherapy (pemetrexed and carboplatin) | 1 |
| CT-95 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Colorado | 1 |
| Illinois | 1 |
| Michigan | 1 |
| New Jersey | 1 |
| Pennsylvania | 1 |
| Tennessee | 1 |
| Texas | 1 |
Top cities
Chicago, Illinois 1Denver, Colorado 1Grand Rapids, Michigan 1Hackensack, New Jersey 1Nashville, Tennessee 1Philadelphia, Pennsylvania 1San Antonio, Texas 1
Self-screener
Recruiting trials
- Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
- CT-95 in Advanced Cancers Associated With Mesothelin Expression
Related conditions
Trials recruiting for Lung Adenocarcinoma Metastatic often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Pancreatic cancer 870Pancreatic Adenocarcinoma Advanced or Metastatic 3Epithelial Ovarian Cancer 10Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Lung Adenocarcinoma Metastatic trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.